Ardent Health Q2 net income $17M ($0.12 EPS) vs $73M; Adjusted EBITDA $115M, down 32% YoY

Ardent Health, Inc.

Net income attributable to Ardent Health $17M ($0.12 diluted EPS) vs $73M ($0.52) in Q2 2025; revenue $1.62B, down 1.4% YoY.
Adjusted EBITDA $115M, down 32.3% YoY; operating cash flow $197M, up 67% YoY.
Reaffirmed FY2026 guidance: revenue $6.4B-$6.7B, Adjusted EBITDA $485M-$535M; lowered net income guidance to $110M-$163M.
IMPACT program savings target raised to at least $70M in 2026 (from $55M); repurchased 1.4M shares for $13M in Q2.
Admissions down 1.0%, surgeries down 2.9% YoY; adjusted admissions up 2.5%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.